Prescriber adherence to treatment guidelines for monoclonal antibodies against Calcitonin Gene-Related Peptide in migraine prophylaxis – a register-based cohort study

Abstract Background Calcitonin Gene-Related Peptide targeting monoclonal antibodies (CGRP mAbs) were introduced for migraine prophylaxis in Sweden through the National Joint Introduction process to ensure an equal, cost-effective, and appropriate national use. This study aimed to assess prescriber a...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Sofia Nordenmalm, Rickard E. Malmström, Sara Freyland, A. Ingela M Nilsson Remahl, Karin Wirdefeldt, Isabella Ekheden
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2026-03-01
Rangatū:	The Journal of Headache and Pain
Ngā marau:	Migraine disorders Calcitonin gene-related peptide Calcitonin gene-related peptide receptor antagonists Antibodies, monoclonal Managed care programs Practice guidelines as topic
Urunga tuihono:	https://doi.org/10.1186/s10194-026-02322-1
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!